S&P 500: 662.29 -0.6% NASDAQ 100: 593.72 -0.6% Dow Jones: 466.41 -0.2%

AbbVie Inc.

ABBV Healthcare
$219.68 $-5.69 (-2.52%)
Market Cap: $388.43 B
Gurus Holding
16
Popularity Rank
#99
% of Shares Held
0.13%
Net Activity (Q4 2025)
-$202.88 M

Guru Ownership Trend

Guru Analysis for AbbVie Inc. (ABBV)

AbbVie Inc. (ABBV), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 16 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $518.16 M.

Top institutional holders include Cliff Asness and Ken Fisher.

Notably, Robert Bruce has expressed high conviction in this stock, allocating 8.68% of their equity portfolio to it.

Institutional sentiment is currently Bearish. This is evidenced by a $202.88 M net outflow during the quarter.

Recent activity highlights Ken Fisher who increased their stake by 127.8%. Conversely, Ray Dalio reduced exposure by 94.6%.

Key Holders

Top 5 by Value

$262.93 M
$143.57 M
$27.99 M
$25.94 M
$23.64 M

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$167.11 M
Total Buy Value
New Buys 1
Additions 5
-$369.99 M
Total Sell Value
Reductions 7
Sold Out 3

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
10
Net Buyers
6

FAQs for AbbVie Inc. (ABBV)

Major holders include Cliff Asness ($262.93 M), Ken Fisher ($143.57 M), Robert Bruce ($27.99 M). According to the latest reported data, 16 tracked investment managers collectively hold approximately 2.36 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $202.88 M, with 6 managers increasing positions and 10 managers reducing holdings.

During the most recent reporting period, 7 managers trimmed their positions, while 3 fully exited ABBV. The total reported sell value was $369.99 M.

Yes, 1 managers opened new positions in ABBV, and 5 increased their existing holdings. The total reported buy value was $167.11 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.14% Add 24.2% 1,150,746 $262.93 M Q4 2025
0.05% Add 127.8% 628,338 $143.57 M Q4 2025
8.68% Reduce -3.9% 122,500 $27.99 M Q4 2025
0.05% New Buy 113,543 $25.94 M Q4 2025
0.12% Add 3.8% 103,457 $23.64 M Q4 2025
0.07% Add 77.5% 86,014 $19.65 M Q4 2025
0.10% Reduce -2.0% 46,456 $10.61 M Q4 2025
1.00% Reduce -0.9% 31,197 $7.13 M Q4 2025
0.06% Reduce -4.0% 19,541 $4.46 M Q4 2025
0.03% Reduce -0.1% 15,252 $3.48 M Q4 2025
0.01% Reduce -94.6% 14,209 $3.25 M Q4 2025
0.03% 12,410 $2.84 M Q4 2025
1.49% Reduce -3.0% 6,720 $1.54 M Q4 2025
0.00% 6,454 $1.47 M Q4 2025
0.03% 1,491 $340,637 Q4 2025
0.00% Add 34.9% 356 $81,787 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form